Skip to content

The Role of Cathepsin X in Infection With the Helicobacter Pylori

Helicobacter Pylori and Gastric Cancer - the Role of Cytokine Polymorphism, Cytokine Expression and Expression of TLR on Persistence of Helicobacter Pylori Infection and Development of Gastric Cancer.

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01137942
Enrollment
14
Registered
2010-06-07
Start date
2008-11-30
Completion date
2010-07-31
Last updated
2010-07-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Persistence of Infection With Helicobacter Pylori

Keywords

helicobacter pylori, eradication failure

Brief summary

The immune response to Helicobacter pylori (Hp) importantly determines the pathogenesis of infection as well as the success of antibiotic eradication of the bacteria. The investigators want to demonstrate the importance of cathepsin X (CTSX), a cysteine protease, for the Hp eradication success. The diversity of the innate immune response to H. pylori antigens leading to either successful eradication of the infection or maintenance of chronic inflammation is connected to CTSX. The aim of this study is to determine whether H. pylori suppresses the CTSX expression and cytokine secretion in macrophage cell line THP-1 in the individuals that are not capable of eradicating the infection, opposite to H pylori in patients with successful H pylori eradication . The investigators also investigate the possibility whether strain-dependent differences in H. pylori lipopolysaccharide (LPS) influence the CTSX expression and cytokine secretion.

Interventions

DRUGclarithromycin, metronidazole, proton pump inhibitor

appropriate dose of antibiotics and proton pump inhibitor

Sponsors

University Medical Centre Ljubljana
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

People with helicobacter gastritis and Helicobacter sensitive to antibiotic therapy but failure of therapy -

Exclusion criteria

People with helicobacter gastritis who did not eradicate Helicobacter pylori because of primary resistance to antibiotics. \-

Design outcomes

Primary

MeasureTime frameDescription
Evidence that cathepsin X influences on the eradication of Helicobacter pylori confirmed by lower expression of cathepsin X and cytokines in those patients. that can not eradicate Helicobacter pylori.7 months after last participant included in the studyThe investigators assume that vast majority of patients, that have problems with eradication of Helicobater pylori, not caused by primary resistence to antibiotics, can not eradicate helicobacter because of inappropriate immune response. The investigators will measure cathepsin X (CTSX) expression and assume that those patients who have low concentrations of CTSX also have inappropriate immune response seen in low levels of cytokines. To treat such patients, you need to give them different and longer antibiotic therapy.

Countries

Slovenia

Contacts

Primary ContactAlojz Ihan, MD, PhD
alojz.ihan@mf.uni-lj.si0038615437493
Backup ContactMiha Skvarc, MD
miha.skvarc@mf.uni-lj.si0038615437484

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026